A pilot study to determine whether increasing oxygen flow rate or oxygen percentage through a fixed performance mask relieves breathlessness in patients with cystic fibrosis
Completed
- Conditions
- utritional, Metabolic, Endocrine: Cystic fibrosisNutritional, Metabolic, EndocrineCystic fibrosis
- Registration Number
- ISRCTN60112193
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2006 Update - Department of Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Cystic fibrosis patients aged over 16
2. Clinically stable
3. Able to give informed consent
Exclusion Criteria
Patients having respiratory exacerbation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method